Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin B1 (CCNB1) is a regulatory protein essential for controlling the cell cycle at the G2/M transition. It forms a complex with cyclin-dependent kinase 1 (CDK1), creating the maturation-promoting factor (MPF), which is crucial for initiating mitosis. Overexpression of CCNB1 is observed in various cancers and associated with aggressive tumor behavior and poor clinical outcomes, making it a potential therapeutic target.
Inhibition of CDK activity through disruption of cyclin binding or by targeting upstream regulators of CCNB1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 1 regulatory subunit 2 (CCNB1).